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Abstract
The purpose of this evidenced-based quality improvement project is to implement processes to
facilitate providers’ adherence to the American Diabetes Association (2017), American
Association of Clinical Endocrinologist (2015), and American College of Endocrinology (2015)
immunization guidelines for adults with type II diabetes. Presently, diabetes is the 7th leading
cause of death in the United States contributing to serious complications throughout the body as
a result of poor glucose control. Adults with diabetes are at increased susceptibility to infectious
disease because of hyperglycemia, poor glucose control, and decreased immunity. A protocol
was created using The Four Pillars Transformation Program ™ to align provider practices at a
family practice clinic with recommended guidelines. Interventions aimed at improving
recommended vaccination rates in adults with type II diabetes mellitus include standing orders
for all immunizations, a vaccine clinic that operates simultaneously during office hours, vaccine
needs screening, patient education, flyers, electronic medical record alerts, an appointed
immunization champion, and quality improvement meetings. At project completion 62% of
eligible patients had been screened for vaccine need and 62% received education. Ten weeks
post project implementation, 64% of the eligible patients had been vaccinated with
pneumococcal polysaccharide vaccine 23, 86% pneumococcal conjugate vaccine, 89% tetanus,
and 54% herpes zoster. Thirty-seven out of 49 (76%) eligible patients who received education
received all recommended vaccines indicating a need for continued work on staff and patient
education that will facilitate patient consent for recommended vaccines.
Keywords: Diabetes Mellitus, Pneumovax 23, Tetanus, Herpes Zoster
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Type II diabetes negatively affects cells within muscles, liver, and fat tissue which results
in inappropriate use of insulin (Pratley, 2013). The body’s need for insulin increases and beta
cells located within the pancreas begin to lose the capability to produce adequate amounts of
insulin over time (Pratley, 2013).
Presently, diabetes is the 7th leading cause of death in the United States (Centers for
Disease Control & Prevention [CDC], 2014). Approximately 30 million people in the United
States have diabetes. Death associated with diabetes is 1.5 times higher in adults age 18 or older
with diabetes than those without diagnosed diabetes (CDC, 2014). The direct and indirect cost of
diabetes is estimated to be $245 billion annually in the United States (CDC, 2014). Diabetes
contributes to serious complications throughout the body, as a result of poor glucose control
(CDC, 2014). Adults with diabetes are at increased susceptibility to infectious disease because of
hyperglycemia, poor glucose control, longer duration of diabetes, decreased immunity, and
impaired pulmonary, renal, and liver function.
Statement of the Problem
It is estimated that 29.1 million Americans have diabetes (CDC, 2014). Adults age 65 or
older account for 11.8 million of the estimated population of adults with diabetes (CDC, 2014).
Adults with type II diabetes mellitus acquire infectious diseases more frequently and severely
than adults without diabetes because of the hyperglycemic environment which causes a reduction
in T cell response, neutrophil functioning, and humoral immunity disorders (Casqueiro,
Casqueiro, & Alves, 2012). Herpes zoster, tetanus, and pneumococcal disease commonly occur
in adults with type II diabetes, but each of these diseases is preventable through the use of
recommended vaccinations. Presently there is a lack of adherence to immunization guidelines in
family practice settings (Alcusky & Pawasauskas, 2015).
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Background and Significance
The most frequently occurring infectious diseases in patients with type II diabetes are
Streptococcus pneumonia and influenza virus (Casqueiro et al., 2012). Individuals with type II
diabetes who acquire pneumonia or influenza are six times more likely to require hospitalization
than non-diabetics (Casqueiro et al., 2012). Yende et al. (2010) conducted a retrospective
analysis on two multicenter cohorts to help determine the effect pre-existing diabetes has on
morbidity and mortality after a patient is infected with community acquired pneumonia. The
study found diabetes increases the rate of mortality within the 1st year following infection with
community acquired pneumonia (Yende et al., 2010). Yende et al. (2010) also found adults with
diabetes have a higher risk of acute kidney injury during hospitalization for community acquired
pneumonia (39.3%) vs 31% of adults without diabetes. It is estimated that pneumococcal
vaccines are 84% effective in patients with diabetes age 18-64 and 44% effective in adults age 65
or older against pneumococcal bacteremia (Kesavadev et al., 2012). The pneumococcal
polysaccharide vaccine 23 (PPSV23) and pneumococcal conjugate vaccine (PCV13) contain
polysaccharide antigens that induce an antibody response which destroys pneumococcus seven to
10 days after vaccination (Kesavadev et al., 2012). In 2014, the National Health Interview
Survey (NHIS) conducted a cross-sectional household survey and found the national vaccine rate
for PPSV23 and PCV13 was 20.3% (Williams et al., 2016). Similarly, Alcusky and Pawasauskas
(2015) found adherence to national pneumococcal vaccine guidelines was 37% in a singlecenter, cross-sectional study conducted on 100 medical records.
Herpes zoster virus presents as a painful, vesicular rash, which can be complicated by
secondary infections (Karla & Chawla, 2016). It commonly occurs in adults with diabetes
because of the immune-compromised state (Karla & Chawla, 2016). A decline in varicella zoster
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virus related cell-mediated immunity is seen in adults with diabetes which results in a higher
incidence of herpes zoster virus in these individuals (Karla & Chawla, 2016). Post-herpetic pain
has a higher prevalence in adults with diabetes as well (Karla & Chawla, 2016). Diabetes
increases the risk of acquiring herpes zoster by 2.1% (Aldaz et al., 2013). The 2014 NHIS survey
found that herpes zoster vaccination coverage amongst adults age 60 and older was 27.9%
(Williams et al., 2016). The Center for Disease Control and Prevention analyzed data from the
2014 NHIS and found Whites have the highest rate of herpes zoster vaccine coverage at 32%,
with Blacks 11.6%, Hispanics 14.6%, Asians 16.5%, and those reporting other race 16.2%
(Williams et al., 2016). The herpes zoster vaccine (Zostavax®) reduces the risk of developing
shingles by 51% and post-herpetic neuralgia by 67% (CDC, 2016). The herpes zoster vaccine is
thought to stimulate the body’s immune system through a weakened strain of the chickenpox
virus which helps keep the virus dormant (CDC, 2016).
Tetanus is a vaccine-preventable disease that is life-threatening (Williams et al., 2016).
Clostridium tetani, the bacteria causing tetanus, is found in high concentrations in soil and
animal excrement (Williams et al., 2016). It presents with acute onset of hypertonia and painful
muscle contractions that have no obvious cause (Williams et al., 2016). Adults with diabetes are
at an increased risk of acquiring tetanus (Williams et al., 2016). The prevalence of tetanus in
individuals with diabetes is three times higher than those without diabetes (Williams et al.,
2016). Chronic wounds or infections which are common in diabetes increase the risk by 13%
(Williams et al., 2016). The 2014 NHIS survey found that only 64.7% of adults aged 50-64 and
57.7% of adults age 65 or older had received any tetanus toxoid containing vaccine within the
past 10 years (Williams et al., 2016). There are four vaccines which protect against tetanus in
combination with other vaccines: DT (diphtheria and tetanus), DTaP (diphtheria, tetanus, and
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pertussis), Td (tetanus and diphtheria), and Tdap (tetanus, diphtheria, and pertussis) (CDC,
2016). The vaccines offer protection from tetanus due to the neutralizing antibodies from the
tetanus toxin and as a result cause a rise in tetanus antibody concentration after vaccination
(CDC, 2016).
Assessment
A pre-intervention retrospective medical record review of 155 adults with type II diabetes
was conducted from November 1, 2016, through January 31, 2017, at a family practice clinic.
The majority of the patients were privately insured (60%), white (91%), and non-Hispanic
(60%). Fifty-nine (38%) of the adult patients with type II diabetes were age 30 to 49, 25 (16%)
age 50-64, and 70 (45%) age 65 or older.
The pre-intervention retrospective chart review demonstrated that ninety (58%) of the
adult patients with type II diabetes had a HbA1c greater than or equal to 6.5 placing them at high
risk for acquiring infectious disease. Thirty-seven (41%) of the ninety patients at high risk for
infectious disease were treated with antibiotics for bacterial infections within the past year. The
clinic vaccination rates in adults with type II diabetes were influenza PVC13 (49%), PPSV23
(21%), tetanus (24%), and herpes zoster (17%) which further increases the susceptibility of
disease in this already vulnerable population (Table 1).
Readiness for Change
A review of the ADA, AACE, and ACE guidelines and the results of the December 2016
microsystem assessment with key stakeholders at the family practice clinic resulted in a
determination that the clinic does not have a process in place to facilitate immunizing adults with
type II diabetes. Prior to the review of the guidelines the providers and staff were unaware of the
high risk of morbidity and mortality associated with vaccine preventable infectious disease and
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the current immunization guidelines for adults with type II diabetes. Following the guideline
review it was determined that a process improvement project would be created to align the
practice with the ADA, AACE, and ACE guidelines and all providers and staff expressed a
desire to improve the immunization rates for adults with type II diabetes. The clinic’s resources
are able to support the performance improvement project through the use of space, technology,
training, and organizational structure.
Table 1
Clinical Characteristics of Pre-intervention Patient Population
Demographics

Hemoglobin A1c
≥ 6.5
<6.5

Percentage

58%
42%

Infectious Disease Treated with Antibiotics
Upper Respiratory Infection
Bronchitis
Sinusitis
Cellulitis
Conjunctivitis
Pharyngitis
Otitis
Pneumonia
Folliculitis

20%
14%
35%
26%
16%
39%
27%
5%
6%

Recommended Immunizations Administered
PVC13
PPSV23
Tetanus
Herpes Zoster

49%
21%
24%
17%

Project Purpose and Objectives
The purpose of this quality improvement project was to implement processes to facilitate
providers’ adherence to the ADA (2017), AACE (2015), and ACE (2015) immunization
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guidelines for adults with type II diabetes at a family practice clinic. The ADA (2017)
recommends all adults with type II diabetes receive by age group:


19-64: PPSV23



65 or older: PVC13 and PPSV23

The AACE (2015) and ACE (2015) also support the above recommendations, but in addition
these two organizations recommend all adults with type II diabetes receive by age group:


18 and older: tetanus-diphtheria booster every 10 years



60 and older: varicella zoster (Handelsman et al., 2015).

The objectives of this evidence-based quality improvement project are to increase the percentage
of adult patients with type II diabetes who receive vaccine needs screening, education, and
recommended vaccines (Table 2).
Table 2
Objectives and Anticipated Outcomes

Project Objectives

Anticipated Outcomes

Screening for Vaccine Need

Increase from 0% to 60%

Patient education

Increase from 0% to 60%

Administration of PPSV23

Increase from 21% to 41%

Administration of PVC13

Increase from 49% to 69%

Administration of tetanus

Increase from 21% to 41%

Administration of herpes zoster

Increase from 21% to 41%
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Summary and Strength of the Evidence
Methods which can improve immunization rates are vaccine needs screening, patient
education, immunization access, and education. Studies that implemented or analyzed The Four
Pillars Practice Transformation Program™ were synthesized and resulted in the information used
to create the immunization protocol for adults with type II diabetes in the clinic.
Lin et al. (2016) conducted a randomized cluster trial of 70,549 adults seen in twenty-five
primary care clinics over a 1 year period. The study used The Four Pillars Practice
Transformation Program™ to increase adult influenza vaccination rates and reduce missed
opportunities to vaccinate patients. The program included provider and staff education on the
importance of protecting patients from vaccine preventable diseases and strategies to overcome
common barriers patients and providers often face (Lin et al., 2016). The study also identified an
immunization champion who was responsible for updating the project outcome dashboard,
assuring the strategies were implemented, and providing motivation for the staff (Lin et al.,
2016). During the study, access to vaccinations was increased by using each patient visit as an
opportunity to vaccinate, holding express vaccination clinics outside of normal clinic hours, and
creating a dedicated vaccination station (Lin et al., 2016). Communication with patients about
the importance of vaccination was done by using posters, fliers, social media vaccination
prompting, and outreach email and phone calls (Lin et al., 2016). Office systems were enhanced
to facilitate adult vaccinations by assessing immunizations as part of vital signs, incorporating
standing order procedures (SOP), and promoting simultaneous vaccination. One year after
initiating these interventions, the influenza vaccination rate increased by 2.7% to 6.5% from
baseline per practice (Lin et al., 2016). Similarly, Nowalk et al. (2014) conducted a qualitative,
triangulated, mixed method design study using the 4 Pillars Practice Transformation Program™

Improving Recommended Vaccination Rates in Adults

16

to improve influenza and pneumococcal vaccination rates in adults (Nowalk et al., 2014). The
study was conducted at four primary care practices within the same county of Pennsylvania
(Nowalk et al., 2014). Each clinic was encouraged to implement interventions from The Four
Pillars Practice Transformation Program™ that best fit their practice. In the 1st year
pneumococcal vaccination rates increased significantly by 25% and in the 2nd year the rates
increased by 40% from baseline. Three of the four clinical sites saw improved influenza
vaccination rates. The overall improvement rate for influenza vaccination was 22% during the
1st year and 33% during the 2nd year. The study found the greatest rates of improvement were
seen in clinics that more fully implemented The Four Pillars Practice Transformation Program™.
Zimmerman et al. (2017) also conducted a cluster randomized trial using The Four Pillars
Practice Transformation Program™ to determine if it would increase pneumococcal
immunization rates in older adults (Zimmerman et al., 2017). This study used a sample from
twenty-five primary care practices with 18,107 participants age 65 or older. The study
implemented interventions which included convenient vaccination services, communication with
patients about the importance of immunizations, enhanced office systems, and motivation
through an office immunization champion (Zimmerman et al., 2017). Like previous studies,
during the 1st year vaccination rates increased 6.5% to 8.7% per practice (Zimmerman et al.,
2017). By the end of the 2nd year, 79% of participating primary care practices had PPSV23 rates
at or above 70% (Zimmerman et al., 2017). The Four Pillars Practice Transformation Program™
uses an evidence-based method to systematically improve immunization rates. The program was
not found in a published study of adults with type II diabetes or for improving tetanus and herpes
zoster immunization rates, but multiple studies have proven its efficacy making it feasible in
these situations.
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Methods
Project Intervention
The project setting is a privately owned family practice clinic located in a small Texas
suburb. The providers currently care for 12,059 patients. Over the past year, 512 clinic patients
were adults with type II diabetes. The clinic has been owned and operated by the lead physician
for the past 22 years. The clinic is staffed with five providers, five medical assistants (MA), two
receptionists, one office manager, one biller/coder, and one information technologist. The top
five ICD-10 diagnoses in the clinic are essential hypertension, type II diabetes, generalized
atherosclerosis, disorder of lipid metabolism, and adult health exam.
An evidence-based practice project was implemented to increase provider and MA
adherence to ADA (2017), AACE (2015), and ACE (2015) guidelines for immunizations in
adults with type II diabetes. The project interventions designed to increase adherence included an
education/discussion session for providers and staff, using a vaccine needs assessment
(Appendix A), implementing standing orders, appointing an immunization champion, building
an electronic medical record (EMR) alert, providing patient education (Appendices B & C), and
bi-weekly quality improvement meetings (Table 3).
Prior to project implementation, an interactive group education session was conducted
with all providers and MAs. The education session provided information on type II diabetes and
guidelines for recommended vaccines including background, significance, vaccine needs
assessment screening, and The Four Pillars Practice Transformation Program™.
The clinic presently has an SOP for influenza, PVC13, and PPSV23 immunizations. Prior
to project implementation the clinic adopted an SOP for tetanus and herpes zoster vaccines. The
clinic selected to use pre-printed standing orders provided by the Immunization Action Coalition
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Table 3
Interventions Based on The Four Pillars Practice Transformation Program™.
Intervention

Responsible Party

Pillar 1: Convenient Vaccination Services
Standing Orders for all Immunizations
A vaccine clinic that runs
simultaneously during office hours

Physician, Project Leader
Medical Assistants

Pillar 2: Communication with Patients About the Need for Vaccinations and Availability
Vaccine needs screening
Patient education
Flyers

Receptionist, Medical Assistant,
Providers
Medical Assistants, Providers
Medical Assistant

Pillar 3: Enhanced Electronic Office Systems to Facilitate Immunizations
Electronic medical record alert for
influenza, PVC13, PPSV23, tetanus, and
herpes zoster vaccines

Physician Owner, Project Leader

Pillar 4: Motivation Through the Use of an Immunization Champion
Pre-intervention interactive group education
Appointment of an immunization champion
Biweekly Quality Improvement meetings

Project Leader
Physician Owner
Providers, and Project Leader

(n.d.) which include Standing Orders for Administering Tdap/Td Vaccine to Adults (Appendix
D), and Standing Orders for Administering Zoster Vaccine to Adults (Appendix E). The SOPs
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were reviewed by the project leader, all providers, MAs, and the office manager. The medical
director signed the SOPs and added them to the facility’s SOP manual.
Prior to implementation of the project, the EMR was reconfigured to include quality
indicator alerts for tetanus and herpes zoster vaccines for all adults with type II diabetes.
Influenza, PVC13, and PPSV23 alerts were already programed into the EMR. All recommended
immunization identifiers are located under the quality tab and have a red alert that indicates
attention is required.
On the 1st day of implementation each patient age 18 or older entering the clinic was
given by the receptionist a copy of the vaccine needs assessment to complete. After completion,
the patient gave the form to the MA. The MA used the vaccine needs assessment to identify
which vaccines were recommended and documented the vaccine administration in the electronic
medical record. All adult patients with type II diabetes were given the handout What You Need to
Know About Diabetes and Adult Vaccines in English or Spanish based on the language of their
choice (U.S. Department of Health and Human Services Centers for Disease Control and
Prevention, 2015). The MA initialed the vaccine needs assessment indicating it was reviewed
and initialed the box on the vaccine needs assessment indicating patient education was presented.
The MA answered any patient questions. The MA then placed the vaccine needs assessment in
the designated file folder in the patient room for the provider.
The provider reviewed the vaccine needs assessment with the patient and discussed
recommended vaccinations with the patient. The provider answered any patient questions. The
provider initialed the vaccine needs assessment indicating it had been reviewed and documented
any vaccine orders, refusal, or contraindications to the recommended vaccine in the electronic
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medical record. Upon leaving the patient’s room the provider handed the vaccine needs
assessment to the MA, and discussed recommended vaccines.
The MA prepared the recommended vaccines at the vaccine station. The MA entered the
patient’s room and handed the patient a copy of each vaccine’s information sheet. The MA
answered patient questions and administered the vaccines. The MA documented vaccine
administration in the electronic medical record.
The patient then checked out at the front receptionists’ desk. The receptionist viewed
upcoming immunization recommendations in the electronic medical record. The receptionist
scheduled an appointment for the patient to see the MA for future immunizations.
Organizational Barriers and Facilitators
The organization had multiple challenges to overcome during the implementation of the
new protocol. Barriers included staff turnover, immunization stock, and insurance coverage.
Following staff education but prior to project implementation, one provider and one MA left the
practice. During the project these positions were not filled. This resulted in higher patient
volumes for both providers and MAs. During the 2 weeks post implementation quality
improvement meeting staff reported it was difficult to assess immunization status on acute
patient visits because acute patient visits were only scheduled for fifteen minute blocks. To
overcome this problem the MAs began using the SOPs and administered the patient’s
recommended vaccine prior to having the provider enter the room. This eliminated the need to
have the MA return to the patient’s room a 2nd time. During the 4th and 6th week’s quality
improvement meetings all three MAs reported time was no longer an issue for acute visits.
The implementation of screening all patients through the use of a vaccine needs
assessment resulted in increased vaccination rates for all patients including those without type II
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diabetes. Though an increase was anticipated, the clinic did not fully predict the degree of
increase. During the 1st 2 weeks of project implementation the clinic ran out of the tetanus
vaccine. During this time two patients were not vaccinated and instructed to return to the clinic at
their next scheduled visit for the vaccine. A written vaccine reminder was also placed in both
patients’ medical records. Both patients returned to the clinic within 4 weeks and received the
recommended vaccine. During the 6th week the clinic again ran out of tetanus vaccine. One
patient did not receive the vaccine at this time and was instructed to return to the clinic in 4
weeks to receive the vaccine. The patient did return to the clinic for his scheduled vaccine.
During the 6th week’s quality improvement meeting it was noted that all vaccine administrations
were being logged but it was still impossible to predict how many vaccines might be
administered in one week. The rate ranged from one to 20 vaccines per week. The clinic agreed
to keep 20 doses in stock for the remainder of the project.
Despite ADA, AACE, and ACE recommendations to vaccinate all adults with type II
diabetes with herpes zoster vaccine at age 50, the Center for Disease Control does not
recommend vaccination until age 60. The CDC (2016) reports protection from shingles vaccine
only lasts about 5 years and the risk of complicated shingles occurs later in life. Following
project implementation the clinic found most commercial insurances would not cover herpes
zoster vaccination until the patient is age 60. During week two’s quality improvement meeting
the clinic decided to only offer the vaccine to patients age 60 or older for the remainder of the
project.
Facilitators of the new protocol included the familiarity of the clinic staff with vaccine
administration and standing orders, an affiliation with drug companies that produce vaccines,
increased revenue from enactment of the vaccine protocol, and patient willingness to participate
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in the project. The expertise of the clinic staff with the process of scheduling patients for
immunization appointments and the use of SOPs were additional facilitators.
The clinic received increased revenue based on increased immunization visits and
billable procedures involved in the operationalization of the vaccine protocol. The use of national
guidelines for immunizations in adults with type II diabetes increased insurance reimbursement,
decreased the chance for denial of benefits, and improved adherence to government sanctioned
quality measures.
Ethical Considerations
The herpes zoster vaccine was created using descendant cells taken from an electively
aborted fetus approximately 40 years ago (The College of Physicians of Philadelphia, 2017). The
official position of the National Catholic Bioethics Center (2006) is complex and multifaceted
and requires individuals to examine the problem and history, moral and ethical considerations,
and use these factors to guide their decisions on the use of herpes zoster vaccine.
The Catholic Church acknowledges that some vaccine-preventable illnesses are epidemic
in certain parts of the world and can cause serious adverse effects and even lead to death
(National Catholic Bioethics Center, 2006). Vaccines are created by growing a weakened viral
strain in a medium or cell culture (The Right to Life of Michigan, n.d.). The virus then invades
the culture, grows, and multiplies resulting in a weakened vaccine (The Right to Life of
Michigan, n.d.). In the case of herpes zoster vaccine, cells were obtained from cell line MCR-5
from an aborted fetus (The Right to Life of Michigan, n.d.). Cell line MCR-5 originated from
fetal lung tissue take from a 14 week gestation male fetus that was aborted for psychiatric
reasons in 1966 (The Right to Life of Michigan, n.d.). The aborted fetus was healthy and had no
life-threating conditions (The Right to Life of Michigan, n.d.).
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People are justified in wanting to protect themselves, their children, and their community
from potentially life-threatening diseases (The Right to Life of Michigan, n.d.). There is also a
moral obligation within society to prevent disease epidemics (National Catholic Bioethics
Center, 2006). The Right to Life of Michigan (n.d.) states, people who morally oppose the use of
a vaccine created from an aborted stem cell line are justified in their opposition. In the case of
herpes zoster vaccine, researchers did not obtain consent from the subjects and knowingly and
purposefully ended the life of the fetus (The Right to Life of Michigan, n.d.). The ultimate
ethical issue is how people should morally handle using a vaccine to protect people from disease
when the vaccine originated from an immoral act of aborting a child.
The Catholic Church has decided that using vaccines is morally permissible, but when
possible, providers should use vaccines not developed using cell strains obtained from an aborted
fetus (National Catholic Bioethics Center, 2006). The Catholic Church also recommends seeking
ethical alternative vaccines and pressuring vaccine manufactures to research and produce
vaccines through morally acceptable means (National Catholic Bioethics Center, 2006). Due to
moral and ethical concerns, the physician owner has chosen not to recommend herpes zoster
vaccine to his patients. He has agreed to order the vaccine if the patient requests the it and he is
allowing the other providers the free will to prescribe the vaccine at their discretion.
Results
The total number of adults with type II diabetes that entered the clinic during the ten
weeks of project implementation was 182. Ninety-seven of the patients were male and 85 were
female. The majority of the patients were privately insured (62%), white (91%), and nonHispanic (60%). Thirty-two (18%) of the adult patients with type II diabetes were age 30 to 49,
68 (37%) age 50-64, and 82 (45%) age 65 or older. One-hundred seven (94%) of the adult
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patients with type II diabetes race were white and 79 (43%) of the patients were Hispanic. The
mean HbA1c was 7.4 and the mean BMI was 32.2 for all eligible patients (Table 4).
Table 4
Post-Intervention HbA1c and BMI Rates
HbA1c

BMI

Mean

7.351

Mean

32.186

Median

6.7

Median

31.050

Std. Deviation

1.9526

Std. Deviation

7.47709

HbA1c ≥ 6.5

108 (59%)

BMI ≥ 30

99 (54%)

HbA1c < 6.5

74 (41 %)

BMI ≥ 25 & <30

62 (34%)

BMI < 25

21 (12%)

Of the 182 adult patients diagnosed with type II diabetes co-morbid conditions included
148 (81%) cardiac, 20 (11%) pulmonary, 32 (17%) endocrine, 24 (13%) psychiatric, 48 (26%)
gastrointestinal, 26 (14%) renal, and 4 (2%) renal. One hundred four (73%) had no history of
smoking, 17 (9%) were current smokers, and 30 (17%) were former smokers.
Of the 182 eligible patients, 100 (55%) were screened over 10 weeks using the vaccine needs
assessment. Vaccine needs assessment screening was completed during 1st and 2nd weeks 39 out
of 62 times (63%), the 3rd and 4th weeks had 15 out of 34 (44%), the 5th and 6th weeks had 16
out of 36 (53%), the 7th and 8th weeks had 12 out of 23 (52%), and the 9th and 10th weeks had
18 out of 29 (62%) (Figure 1). The screening percentage fluctuated throughout the project.
During the 3rd and 4th weeks the staff thought the project had completed and stopped handing
out the screening tool 1 month early. The screening tool was re-implemented in the 5th week.
Reported reasons for not using the vaccine needs screening tool included:


“I forgot.”
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“The patient wasn’t given one at check-in and I didn’t have time to get one.”



“I use the quality tab to notify me when patient’s need vaccines.”



“I’m too busy.”
Screening Completed

Screening Not Completed

100%

63%

62%

56%
47%

54%

44%

46%

Week 3-4

Week 5-6

52%

48%
38%

0%
Preintervention

Week 1-2

Week 7-8

Week 9-10

Figure 1. Pre and post-intervention vaccine needs screening. This figure illustrates the changes
in pre and post-intervention vaccine needs screening.
A Spearman’s rho coefficient was performed on post-intervention data to examine the
relationship between screening patients for vaccine need and patient receipt of the herpes zoster
vaccine. The relationship between these variables was significant, r = .20, p < .01 (Table 5).
Formal vaccine education was done during the 1st and 2nd weeks four out of 62 times
(6%), during the 3rd and 4th weeks six out of 34 times (18%), during the 5th and 6th weeks 10
out of 36 times (28%), during the 7th and 8th weeks 11 out of 23 times (43%), and during the 9th
and 10th weeks nine 18 out of 29 times (62%) (Figure 2). During the initial phase of the project,
the education handout was not being utilized. During the 6th week of project implementation two
of the providers reported they preferred to give verbal education as opposed to the handout, but
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agreed to provide printed education. At project completion 37 out of 49 (76%) patients who
received formal printed education on vaccines and diabetes received all recommended vaccines.
Table 5
Relationship Between Screening and Administration of Herpes Zoster Vaccine (HZV)
Relationship

Received HZV

Test

Received HZV

Screening

Correlation Coefficient

1.000

.204*

.

.006

N

182

182

Correlation Coefficient

.204*

1.000

Sig. (2-tailed)

.006

.

N

182

182

Sig. (2-tailed)

Screening

Note. *Correlation is significant at the 0.01 level (2-tailed).
Many patients were unaware that specific immunizations are recommended for patients with
type II diabetes. They were also unaware that elevated blood glucose decreases immunity and
places the patient at increased risk of acquiring vaccine preventable diseases. Patients received
PVC13 (81%), PPSV23 (82%), tetanus (76%), and herpes zoster (60%) vaccines after they
received formal printed education indicating a direct correlation between vaccine administration
and patient education. Reported reasons for not using the printed education on diabetes and
vaccines included:


“I forgot.”



“I couldn’t find it.”



“I prefer to do verbal education.”

Improving Recommended Vaccination Rates in Adults

27

A Spearman’s rho coefficient was performed on post-intervention data to examine the
relationship between using formal printed education and the patient receipt of a vaccine. The
relationship between these variables was significant, r = .17, p < .05 (Table 6).
Printed Education Provided

100%

Printed Education Not Provided

94%
82%
72%
57%
43%

62%

38%

28%
18%
0%
Preintervention

6%
Week 1-2

Week 3-4

Week 5-6

Week 7-8

Week 9-10

Figure 2. Pre and post-intervention patient education. This figure illustrates pre and postintervention receipt of patient education.
A chi-square test of independence was performed, including both the pre-intervention and
post-intervention data, to examine the relationship between implementation of The Four Pillars
Transformation Program™ and administration of one or more recommended vaccines. The
relationship between these variables was significant, χ2 (1, 335) = 25.78, p < .05 (Table 7).
At project completion all vaccine administration rates exceeded the project goal of 20%
improvement from pre-intervention rates. Pneumococcal polysaccharide vaccine rates increased
from 21% to 64%, PVC13 rates increased from 49% to 86%, tetanus rates increased from 24% to
89%, and herpes zoster vaccine rates increased from 17% to 54% after 10 weeks of project
implementation (Table 8). Pre-intervention data revealed 79 out of 153 (52%) adults with type II
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Table 6
Relationship Between Education and Vaccination
Relationship
Received at least 1
vaccine

Education

Test

Received at
least 1 vaccine

Education

1.000

.173*

Correlation Coefficient
Sig. (2-tailed)

.

.020

N

182

182

Correlation Coefficient

.173*

.033

Sig. (2-tailed)

.020

.

N

182

182

Note. * Correlation is significant at the 0.05 level (2-tailed).
diabetes received one or more recommended vaccines. Post-intervention 142 out of 182 (78%)
adults with type II diabetes received one or more recommended vaccines.
During the 10 weeks of project implementation multiple patients declined the
recommended vaccines. Three patients declined PVC13, eight patients declined PPSV23, two
patients declined the tetanus vaccine, and two patients declined the herpes zoster vaccine.
Overall, 15 (8%) of the eligible patients with type II diabetes declined the recommended
vaccines. Reported reasons for patients refusal of vaccines included:


“I don’t believe in vaccines.”



“I always get sick after I have a vaccine.”



“I think I have had this vaccine but I don’t remember.”



“I’m sick so I don’t want the vaccine.”



“I’ll get the vaccine at my next appointment.”
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“Vaccines cost too much.”

Table 7
Relationship Between Implementation of The Four Pillars Transformation Program™ and
Administration of One or More Vaccines
Test

Value

df

Asymptotic

Exact

Exact

Significance

Sig. (2-

Sig. (2-

(2-sided)

sided)

sided)

.000

.000

Pearson Chi- Square

25.782a

1

.000

Continuity Correctionb

24.620

1

.000

Likelihood Ratio

25.993

1

.000

Fisher’s Exact Test
Linear-by-Linear Association

1
25.705

N of Valid Cases

1

.000

335

Note. a (0.0%) have expected count less than 5. The minimum expected count is
b

52.07.

Computed only for a 2X2 table
Discussion
The vaccine needs assessment was not consistently administered to all patients that

entered the practice during the project. The absence of completed vaccine needs assessment tools
limited identification of patients who required education and vaccinations. In a study conducted
by Lu, O’Halloran, Ding, Srivastav, & Williams (2016), 87% of unvaccinated high risk adults
attended at least one provider visit in the past year where a vaccine could have been administered
but was missed. At the end of project implementation, 62% of eligible patients were screened
using the vaccine needs assessment tool indicating missed opportunities occurred in 38% of the
eligible patients. In this project screening was shown to have a significant relationship to herpes
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Table 8
Pre and Post-intervention Vaccine Administration Rate
Date

PPSV23

PVC13

Tetanus

Herpes Zoster

Pre-intervention

21%

49%

24%

17%

5/31/17- 6/14/17

64%

83%

62%

44%

6/15/17- 6/28/17

78%

69%

62%

44%

6/29/17-7/12/17

64%

100%

85%

59%

7/13/17- 7/26/17

88%

75%

88%

57%

7/27/17- 8/9/17

64%

86%

89%

54%

zoster vaccine administration. The screening tool served as a way to educate staff and help with
patient decision making while limiting the number of missed opportunities for vaccine uptake.
At 10 weeks post initiation of the interventions, 62% of eligible patients received formal
education. After receiving printed education on diabetes and vaccines 76% of eligible patients
received all recommended vaccines. There was a significant correlation between patient
education and patient consent to vaccines during the project. In a 2012 study of adults age 60 and
older only 14% reported a medical provider discussed the herpes zoster vaccine with them and
59% of the unvaccinated patients reported they would consent to the vaccine after education was
delivered by the provider (Lee et al., 2013). The education flyer served as a way to educate staff
and patients on recommended vaccines and their risks associated with diabetes and vaccinepreventable infectious diseases.
Type II diabetes restricts insulin’s ability to work in the body because the body has
become resistant to insulin, or the body cannot produce enough insulin to lower blood glucose
levels (Knapp, 2013). Chronic hyperglycemia creates an altered immune response making
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susceptibility to infection more common in adults with type II diabetes (Knapp, 2013). The risk
for mortality related to infectious disease is doubled for individuals with a 6.5 HbA1c or higher
compared to those with a 5.2 or lower HbA1c (Breitling, 2016). The post-intervention data
revealed 108 of the 182 (59%) adults with type I diabetes had HbA1c levels greater than or equal
to 6.5, making them highly susceptible to morbidity and mortality associated with vaccinepreventable infectious diseases.
Elevated BMIs place adults with type II diabetes at greater risk for adverse outcomes.
Cardiovascular complications occur in 70.3% of adults with diabetes (Gray, Picone, Sloan, &
Yashkin, 2015). Women have a 1.34 times higher risk of cardiovascular complications when
their BMI is slightly over 25 (Gray et al., 2015). Men have a 1.22 increased risk of
cardiovascular complications when they have a BMI of 27-29 (Gray et al., 2015). The risk
increases with BMIs 30 or higher for both women and men (Gray et al., 2015). Of the 182 adults
with type II diabetes that participated in the quality improvement project, 21 (12%) had a BMI
less than 25, 62 (34%) had a BMI of 25 or greater but less than 30, and 99 (54%) had a BMI of
30 or higher. The post-intervention data also revealed 148 of the 182 (81%) patients had
cardiovascular complications.
The protocol is a practical method for screening, educating, and vaccinating patients with
type II diabetes at risk for acquiring vaccine-preventable diseases. In previous studies, the use of
The Four Pillars Transformation Program™ improved vaccination rates by 2.7% to 25% from
baseline over 1 year (Lin et al., 2016; Nowalk et al., 2014; Zimmerman et al., 2017). Over a 10
week period of time this quality improvement project saw a 37% to 65% improvement from
baseline in PPSV23, PVC13, tetanus, and herpes zoster vaccination rates. The use of The Four
Pillars Transformation Program ™, an immunization champion, and biweekly quality
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improvement meetings was a sustainable way to keep all providers and staff informed about
immunizations and the tools needed to complete the project. Provider adherence to screening,
education, and immunizing patients improved over the course of the project which enabled more
patients to receive recommended vaccinations than prior to project implementation. The Four
Pillars Transformation Program ™ has been previously used in other quality improvement projects
and is transferable to additional practices and other patient populations. The project can easily be
replicated and altered by any medical practice to meet the needs of the clinic.
A significant component of success was the diverse care team, facility culture that
emphasized systems behavior, and motivation from the immunization champion. Both MAs and
providers facilitated communication about immunization needs to patients, families, and each
other. Two weeks post interactive group education all immunization rates increased by 27%43% from baseline. Biweekly quality improvement meetings were initially led by the project
leader then taken over by the providers in the 4th week. Quality meetings allowed providers and
staff the ability to see real-time feedback on the progress made in screening, educating, and
immunizing adults with type II diabetes. During the quality meeting staff roles and
responsibilities were occasionally redefined to support improved processes. Quality meetings
also served as continued reminders to sustain the improvement and as additional motivation for
the providers and staff.
Limitations
The quality improvement project had several limitations as a result of the complexity of
managing multiple interventions including group education, EMR alerts, flyers, standing orders
for all immunizations, a vaccine clinic that runs during office hours, vaccine screening, patient
education, a facility immunization champion, and biweekly quality improvement meetings. The
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multifaceted quality improvement approach for improving immunizations of patients with type II
diabetes did not allow for interventions such as an immunization champion, EMR alerts, quality
meetings, and flyers to be rigorously tested for significance. The project goal was to significantly
improve vaccination rates in an at risk-population therefore making it a priority to create a robust
intervention program with greater likelihood of success as opposed to testing each intervention
separately.
An additional limitation was the time restriction on project implementation. During the
10 week period of time 182 adults with type II diabetes entered the clinic. A longer time period
for project implementation may have increased the number of eligible patients and further tested
the project’s sustainability through bi-weekly quality meetings, and supervision and motivation
from the immunization champion.
The majority of the patients were privately insured (62%), white (91%), and nonHispanic (60%) which does not include marginalized or underserved populations. This project
was limited in the ability to directly implement the project in another setting as the population
and providers were limited in diversity. The clinic is a small privately owned practice and more
diversity may be seen in large corporately owned practices or government run facilities.
Another limitation is this project was conducted with readily available vaccines
purchased by the clinic. Many practices have limited finances to purchase vaccines, and must
follow regulations provided by government programs and grants with the consideration of
vaccine purchasing. The project intervention strategies did not consider inadequate or limited
vaccine supplies.
Recommendations
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The clinic’s pre-intervention immunization rate for adults with type II diabetes mirrored
local and national averages indicating a significant need for quality improvement projects aimed
at improving vaccination rates in the family practice setting. This project focused on improving
PPSV23, PVC13, tetanus, and herpes zoster vaccination rates in adults with type II diabetes. The
processes and interventions can be applied to any quality improvement initiative focused on
improving vaccination rates. In this project the key interventions implemented for improving
administration of recommended vaccines were vaccine needs assessment screening and
providing education to facilitate patient’s informed decision making. Further exploration into
additional interventions is necessary to identify why 24% of the patients with diabetes who
received printed education chose not to receive recommended vaccinations. In a triangulated,
mixed methods study conducted by Nowalk et al. (2014), using The Four Pillars Transformation
ProgramTM, it was discovered that despite education staff generally feel unprepared to deal with
patient’s refusal of vaccines. Nowalk et al. (2014) suggests creating prewritten staff responses
for patients who refuse vaccines. During this project, reasons for refusal were not documented in
the EMR and may have helped staff and providers understand patient’s fear, knowledge, and
misinformation about specific vaccines. Modifications to the current EMR quality indicators
should be considered and include a section that lists reasons for vaccine refusal. An additional
next level alert that indicates the patient needs further education on vaccines could also benefit
this population. During future appointments the alert will remind the provider to revisit the
immunization discussion which should include benefits of each vaccine and risks associated with
diabetes and vaccine-preventable disease.
Though interventions such as an immunization champion and biweekly quality meetings
were not rigorously tested for significance in this project, they served as a way to facilitate a
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systems culture within the practice. The immunization champion served as a resource and
motivation for the team. The immunization champion selected was an MA who understood all
staff roles within the practice. Biweekly quality meetings facilitated teamwork, increased
awareness and accountability, and served as motivation to improve vaccination rates. Daily team
huddles were not used in this project, but have been proven to be a useful way to improve
communication, team work, patient flow, and quality of care delivered. A team huddle could be
an effective way to review patients’ missing immunizations before the patients arrive for the day
and identify potential issues with vaccine stock or educational materials.
During the project multiple patients reported they believed they had received a specific
vaccine but did not have a record for it. In future projects the implementation of a health
information exchange program prior to project implementation would allow for online
movement of patient’s health information amongst healthcare providers. Patient information
from previous medical visits or hospitalizations can be accessed by the provider regardless of
where the patient seeks care which can reduce fragmented care. This intervention could eliminate
redundancy in patient’s immunizations and minimize the risk of patients not receiving
recommended vaccines.
Implications for Practice
Vaccine-preventable infectious disease morbidity and mortality can be prevented through
the use of recommended vaccines. This project has far-reaching public health implications, as it
can provide a path for improving all vaccination rates and thereby increasing herd immunity and
decreasing morbidity and mortality in high-risk populations. Government sanctioned quality
measures currently track PPSV23 and PVC13 vaccination rates for adults with type II diabetes
yet the national and local rates are far below Healthy People 2020’s goal of 60% immunization
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of high-risk adults aged 19-64 and 90% for adults aged 65 and over. These intervention strategies
need to be disseminated to providers to improve the health of adults with type II diabetes.
This project was implemented in a family practice setting and focused on adults with type
II diabetes, but similar quality improvement projects could be implemented in other specialty
practices for patients at risk for acquiring vaccine-preventable diseases. The Four Pillars
Transformation ProgramTM allows the practice the ability to modify and select interventions that
best suit the practices needs making it a feasible tool for any specialty clinic.
Advance Practice Registered Nurses (APRN) with a Doctor of Nursing Practice (DNP)
degree have training and preparation in leadership roles, evaluation and application of evidencebased practice, quality improvement, and organization and systems impact on practice change. A
DNP APRN is uniquely qualified to critique practice and redesign care delivery which can
significantly impact healthcare outcomes such as improving vaccination rates in adults with type
II diabetes. The leadership and clinical skills of a DNP APRN allows for implementation of
evidence-based practice guidelines, such as The Four Pillars Transformation ProgramTM, beyond
the individual providers by focusing on micro and macrosystems.
Conclusion
Type II diabetes remains one of the leading causes of death in the United States. Elevated
blood glucose levels increase the risk of acquiring vaccine-preventable infectious diseases and
accelerates complications in adults with type II diabetes. Despite readily available immunizations
and recommendations from ADA, AACE, and ACE, the national and local PPSV23, PVC13,
tetanus, and herpes zoster vaccination rates in adults with type II diabetes remain low. This
quality improvement project showed significant improvement in PPSV23, PVC13, tetanus, and
herpes zoster vaccination rates in adults with type II diabetes. Interventions based on The Four
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Pillars Transformation ProgramTM were implemented and sustained over 10 weeks. The
successful implementation of these interventions led to a significant increase in post-intervention
screening (62%) and education (62%) rates. At project completion PPSV23 (64%), PVC13
(86%), tetanus (89%), and herpes zoster (54%) vaccination rates also increased in adults with
type II diabetes. The results indicate that formal printed education on diabetes and vaccines
increased vaccine uptake in eligible patients by 76% but further exploration into additional
interventions is necessary to identify why 24% of the adult patients with type II diabetes chose
not to receive recommended vaccinations.
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